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Accepted 17 June 2016; Published online xxxxAbstractAfrica has high disease burden and health system challenges but is making progress in recognizing, accepting, and adopting evidence-
based health care (EBHC). In this article, we reflect on the developments of the past 2 decades and consider further steps that will help with
the translation of reliable research results into the decision making process. There has been a rapid growth in various initiatives to promote
EBHC in the African region. These include the conduct and reporting of primary and secondary research, research capacity development
and supportive initiatives, access to information, and work with decision makers in getting research into clinical guidelines and health pol-
icies. Much, however, still needs to be done to improve the impact on health in the region. A multipronged approach consisting of regionally
relevant well-conducted research addressing priority health problems, increased uptake of research in health care policy and practice, dedi-
cated capacity development initiatives to support the conduct as well as use of research, facilitated by wider collaboration, and equitable
partnerships will be important. Working together in mutually supporting partnerships is key to advancing both evidence-informed health
care practices and better health.  2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in Africa
The disease burden in countries of Africa remains high:
with increases in chronic non-infectious diseases adding to
the already existing large burden of infectious diseases, in-
juries, and maternal and child health conditions [1]. Gov-
ernment health care is poorly resourced in general, with
poor health system infrastructure and limited human re-
sources. In the public sector, global initiatives and funds
from donors can put pressure on existing services by fund-
ing particular initiatives, such as targeted disease control
programs. These can distort national priorities and human
resource allocations.
The formal private sector though not well developed is
increasingly becoming so in both middle- and low-
income African countries, whereas the public health care
system is perceived to offer ‘‘poor services for the poor.’’Conflicts of interest: All authors are identified with Cochrane. All
receive grant money from public bodies based on activities related to pro-
ducing systematic reviews and promoting their uptake.
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licenses/by-nc-nd/4.0/).Under these conditions, individuals and communities
increasingly turn to private health care (formal or informal)
and self-treatment. This may result in their exploitation by
predatory companies making false claims about their prod-
ucts and services, particularly in environments where the
levels of income and education are low and government
regulations non-existent or not enforced. Having ready ac-
cess to reliable health care information will help the public,
clinicians, and governments to make the right choices [2].
Evidence-based clinical care, the integration of current
best available research evidence with clinical expertise
and patient values and preferences, is gaining momentum
in the African region. Whilst initially arising from clinical
medicine to guide clinical decisions, increasingly these de-
cisions impact on national and global policies; and the
methods of research synthesis are being applied to public
health problems. In the context of this broadened agenda,
evidence-based health care (EBHC) and policy is a better
way of describing the current status of shifting from
research into public health policy and clinical practice
and is the scope of this article.
Important strides have been taken to get EBHC onto the
agenda at regional, national, and local levels in some coun-
tries of Africa. In this article, we reflect on theess article under the CC BY-NC-ND license (http://creativecommons.org/
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steps required to ensure that the results of reliable research
continue to inform decision making on the continent.2. EBHC in Africa: the past 2 decades
Globally, there has been an explosion of efforts aimed at
developing research synthesis methods, conducting system-
atic reviews, and designing structured ways of getting evi-
dence into health care policies. People in Africa have
played a key role in this process, mainly through Cochrane.
Since its inception in 1997, Cochrane South Africa has
formed part of this global network. It has worked with
various stakeholders inside and outside of Africa to raise
awareness of the importance of EBHC. It has spearheaded
the conduct and support of regionally relevant Cochrane
Reviews. Data from Cochrane’s contact database in
September 2014 show that the number of Cochrane contrib-
utors from the Cochrane South Africa reference region
(comprising a total of 25 countries in Sub-Saharan Africa)
has increased considerably, with the majority located in
South Africa and Nigeria (Fig. 1). Working with Cochrane
Review Groups for Human immunodeficiency virus (HIV)/
AIDS and Infectious diseases, Cochrane South Africa has
trained, mentored, and supported a large number of African
review authors. An average of 44 full Cochrane Reviews
and 26 protocols were published each year by authors from
Africa during 2009e2013. These authors frequently act as
change agents advocating the use of systematic reviews
within their home institutions and countries [3]. On an in-
ternational scale, they have challenged global policy, for
example, on the use of directly observed treatment strategy
for tuberculosis [4] and continue to contribute to clinical
guideline development. In the recent World Health Organi-
zation (WHO) Malaria guidelines, more than three-quarters
of the 11 Cochrane Reviews informing guideline develop-
ment were authored by Africans [5].0
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Fig. 1. The growth in the number of Cochrane authors in Cochrane
South Africa reference region (2001e2014)dBenin, Botswana,
Cameroon, Comoros, Eritrea, Ethiopia, Gambia, Ghana, Kenya,
Lesotho, Liberia, Madagascar, Malawi, Mauritius, Mozambique,
Namibia, Nigeria, Sierra Leone, Somalia, South Africa, Swaziland,
Tanzania, Uganda, Zambia, and Zimbabwe.Systematic reviews help to identify gaps in the research
base. There has been an increase in research productivity in
the African region since 1991 which has been shown to be
associated with the number of epidemiology training pro-
grams, especially at the masters level [6] and national gross
domestic product [7]. The conduct of randomized trials,
specifically, is being strengthened through funding from
the US National Institutes of Health, Wellcome Trust, and
the EDCTP among others; the development of research
ethics committees; the Pan African Clinical Trials Registry
which allows prospective registration of trials [8,9]; and
dedicated capacity development initiatives primarily
through Masters and PhD programs. While the growth in
research productivity is a welcome development, it remains
unclear to what extent research is being informed by find-
ings from systematic reviews. Furthermore, there is still a
huge discrepancy between research capacity in Africa
compared to that of Europe and North America [10]. This
links with various factors, such as the lack of sustained in-
vestment in research and research capacity building and a
lack of alignment between national and regional priorities
and available funding [11].
The availability of research evidence is, of course, only
one of the inputs into the complex process of health care
decision making [12]. Health care decisions made by policy
makers, health care professionals, managers, researchers,
media, professional associations, and the public at large
are influenced by many factors including cost, feasibility,
and availability of products and services [13]. The priority
given to best evidence in decisions can be influenced by
these, as well many other factors, particularly competing
interests, whether commercial, academic, or political [14].
We have witnessed a positive change in attitudes toward
the use of evidence in health care planning. For example, at
the start of the 21st century, when high rates of mother-to-
child transmission of HIV was an important health prob-
lem, a Cochrane Review was undertaken in response to a
direct request from the South African Department of Health
for evidence on the effects of antiretroviral drugs for its
prevention. On presenting the evidence to key decision
makers, the door was literally closed in the face of the re-
searchers because the evidence did not speak to what the
decision makers wanted to hear. This was an all too typical
case of policy-based evidence (finding evidence to confirm
instead of inform policy decisions) winning over evidence-
based policy [15]. Today, with the caveat that one needs to
be clear on what the phrase means, it is unusual to see any
policy without the words ‘‘evidence based’’ in it.
It must be kept in mind that for evidence-informed pol-
icy making to succeed, proactive engagement of re-
searchers with policy makers and other decision makers
is required. Here, initiatives such as the Effective Health
Care Research Consortium (EHCRC), an international
consortium working closely with African partners, in
Cameroon, Kenya, Nigeria, and South Africa, can be iden-
tified as an example of a group which has had considerable
Box 1 Recommendations from the Kigali
declaration [27]
- A sustainable collaboration to foster evidence-based health
care in Africa is developed
- Health workers, policy makers, and researchers are trained,
and infrastructure is provided to support evidence-based
health care
- Evidence-based health care is integrated into health educa-
tion curricula
- All health workers have access to relevant electronic health
information resources
- Systematic reviews and guidelines relevant to African health
care needs and disease burden are developed
- Health care practitioners, policy makers, and consumers of
health care are supported to identify and use reliable evi-
dence in making health care decisions
- Effective dissemination and implementation strategies are
established
- Research to further strengthen the knowledge base for the
implementation of evidence-based health care in the African
context is encouraged and supported
- Centers and satellite offices for evidence-based health care
are established in countries.
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conducting relevant high-quality reviews which inform
policy and practice. It uses an explicit theory of change
where the production of systematic reviews or their deriv-
ative products are considered outputs. Outcomes of inter-
est include these outputs being accessed and used on the
short term by decision makers, or on the medium
term, to inform new or amended policies or guidelines.
Long-term outcomes comprise EHCRC evidence being
used to influence major funding decisions by bilateral or
multilateral agencies, and an increased number of
evidence-informed decisions being made by intermediary
organizations and networks (e.g., WHO, bilateral) and na-
tional decision makers. Further examples of dedicated ini-
tiatives to promote evidence use in policy making include
the SUPPORT Collaboration which developed tools for
policy makers [16]; the SURE Collaboration [17] which
engages decision makers through deliberate dialogues to
develop evidence-informed policy briefs and by preparing
rapid responses to policy makers in need of research evi-
dence; and Evidence Aid which is seeking to improve ac-
cess to systematic reviews relevant to disasters and other
humanitarian emergencies, such as the ebola outbreak in
West Africa in 2014 [18].
There have also been promising developments in clinical
guideline development and evaluation in the African region
[13,19,20]. For example, Kredo et al. [19] assessed 30
regional guidelines from 13 countries linked to five priority
diseases and found quality gaps in relation to the AGREE II
tool and variable concordance with current best evidence.
In this series, the assessment by Machingaidze [21] ofSouth African primary health care guidelines had similar
findings illustrating the need for dedicated initiatives to
advance and promote guideline development, reporting,
and implementation. Sinclair et al. [13] have similarly
described a project in which researchers worked with the
Ghana National Drugs Program to review the evidence base
for five priority areas in pediatric medicine. They consid-
ered both the international evidence base and the local
applicability of the evidence and presented these as struc-
tured summaries to be used by guideline development
teams.
Indeed, the Paediatric Association of Kenya is using
explicit, transparent guideline development procedures.
They made clear recommendations about stopping bolus
fluids in shocky children based on the totality of the evi-
dence (including the large FEAST trial in Africa evaluating
this) [22], recommendations that the WHO has not yet im-
plemented. This has benefited children by improving clin-
ical care, reducing bolus treatments and saving lives, and
shown that an African country appraise and apply evidence
ahead of any guidelines from WHO.
It is clear that existing international evidence-informed
clinical guidelines are not always taken into account by Af-
rican guideline development groups. This may be due to the
peculiarities of local health systems, such as specific clin-
ical care pathways and resource limitations, knowledge of
evidence, and a reliance on clinical experience. To accel-
erate the availability and implementation of high-quality
local guidelines, a shift from new guideline development
to guideline adaptation [23], application, and evaluation
would be helpful.
There has been recent growing recognition of the need
for EBHC as demonstrated by multiple initiatives to pro-
mote the use of evidence in policy making and practice
(Table 1), the increased number of systematic reviews be-
ing commissioned and funded, and an increase in institu-
tional initiatives to support the conduct of research. There
has also been improved access to evidence through the
HINARI initiative [24] and free one-click access to the
Cochrane Library for people in many African countries.
Furthermore, postgraduate and continuing professional
development courses in EBHC are increasing whether
measured in the number of programs or the number of en-
rollees [25,26]. In 2012, the signing of the Kigali declara-
tion on EBHC [27] by representatives from academia,
hospitals, NGOs, and research institutions from nine Afri-
can countries, forming part of the Collaboration for
Evidence-based Health in Africa, signaled a key milestone
in the recognition of EBHC and the momentum for moving
toward the implementation of evidence-based practices
(Box 1).3. Future role of EBHC in Africa
How can we ensure that all these developments in
EBHC have the greatest impact on improving the lives of
Table 1. Examples of EBHC initiatives in Africadrapid growth in initiatives to promote EBHC
Initiative Short description Website
Alliance for Health Policy and Systematic
reviews (AHPSR)
An international collaboration hosted by the
World Health Organization which goal is to
promote the generation and use of health
policy and systems research as a means to
improve the health systems of LMIC
http://www.who.int/alliance-hpsr/
Collaboration for Evidence Based Healthcare in
Africa (CEBHA)
A network of institutions in Africa engaging in
promoting EBHC in Africa.
http://www.cebha.org/
Development Research Uptake in Sub-Saharan
Africa (DRUSSA)
Provides direct support to universities at
individual, institutional, and systems levels
to improve participation in and impact on
policy and practice.
http://www.drussa.net/
Effective Health Care Research Consortium
(EHCRC)
International consortium focusing on preparing
and updating Cochrane and related Reviews
about the effects of health care relevant to
LMIC; and identifying approaches to ensure
dissemination and use of the results of
systematic reviews in decision making.
http://www.evidence4health.org/
Evidence-Informed Policy Network (EVIPNet) Promotes the systematic use of health research
evidence in policy making focusing on LMIC,
partnerships at the country level between
policy makers, researchers, and civil society
to facilitate both policy development and
policy implementation through the use of the
best scientific evidence available.
http://global.evipnet.org/
Knowledge translation Network (KNET) A network of eight research coalitions with
membership of a coalition of researchers
from nine countries with the overall aim to
promote and support the uptake and use of
research evidence generated by their
coalition partners who are funded by the
Global Health Policy and Health Systems
research program.
http://www.ktnetafrica.net/
Policy BUDDIESdBUilding Demand for
evidence in Decision making through
Interaction and Enhancing Skills
A collaborative project promoting researcher
and policy maker engagement to promote
evidence-informed policy making.
http://www.cebhc.co.za/policy-buddies/
South African Guideline Excellence (SAGE)
project
A collaborative project aiming to, through
engaging in a stakeholder-driven process,
improve the standards of local clinical
guideline development, adaptation,
contextualization and, ultimately,
implementation.
http://www.mrc.ac.za/cochrane/sage.htm
SUPPORT An international Collaboration Network that
involves a partnership between LMIC and
European scientists and LMIC policy makers
to provide training and support to encourage
researchers and policy makers in
collaborative policy-relevant research.
http://www.support-collaboration.org/
Supporting the Use of Research Evidence
(SURE)
A collaborative project that builds on and
supports EVIPNet in Africa and the Region of
East Africa Community Health (REACH)
Policy Initiative.
http://www.who.int/evidence/sure/en/
Global Evidence Synthesis Initiative (GESI) Brings together a number of worldwide
research organizations that are committed to
the development and use of research
synthesis to enhance public policy, public
service delivery, and citizens’ involvement
https://community.cochrane.org/sites/default/
files/uploads/GESI%20-%20Case%20for%
20Support%20-%20March%202015.pdf
Abbreviations: EBHC, evidence-based health care; LMIC, low- and middle-income countries.
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ally relevant and robust research addressing priority health
problems, increased uptake of research in health care policy
and practice, dedicated capacity development initiatives tosupport the conduct as well as use of research, and facili-
tated by wider collaboration will be important. Avoiding
research waste and unnecessary duplication will help
ensure that initiatives remain sustainable.
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New research needs to be informed by the existing body
of research [28,29], and such primary studies and system-
atic reviews must seek to answer relevant research ques-
tions [30]. They should not be driven solely by the
agendas of funders or researchers. In striving for global
excellence and local relevance, African researchers need
to stay abreast of methodological developments and remain
cognizant of research integrity principles. In this series,
Rohwer et al. [31] describe the application of logic model
templates for systematic reviews and health technology as-
sessments of complex interventions. Various postgraduate
programs play a significant role in building relevant capac-
ity [6]. However, these will need to be complemented by ef-
forts to improve science literacy in schools, broad-based
initiatives to empower a critical mass of local researchers
to conduct and deliver internationally competitive research,
support senior researchers to become role models and
leaders, create enabling institutional environments for
research, and build closer relationships between researchers
on the one hand and health decision makers, funders and
the public on the other [11].
Dedicated specialized institutional and regional initia-
tives (centers of excellence) can also make an important
contribution. For example, regional biostatisticians are
joining together to strengthen capacity in biostatistics in
Sub-Saharan Africa by increasing the number, and stan-
dards of, postgraduate programs in biostatistics [32,33] to
facilitate collaborative research initiatives and build biosta-
tistics literacy. This aligns with the INCLEN, the Interna-
tional Clinical Epidemiology Network, which includes
seven regional networks. Through the development of Clin-
ical Epidemiology Units, INCLEN has strengthened
research capacity of medical schools in the African region
[34]. Clinical epidemiologists, as key champions, link with
biostatisticians and other researchers to foster research
conduct and dissemination.3.2. Promoting the use of research to inform policy and
practice
The availability of robust research evidence on its own is
not enough to impact on health care [34e36]. Sensitization
of undergraduatesdthe next generation of health care prac-
titioners, health care managers, policy makers, and
researchersdto the importance of research in decision
making is important. Internationally, there is recognition
and acceptance of the need to include teaching and learning
of EBHC in the training of all health care professionals
[37,38]. Despite this recognition, there is a still a general
lack of coordinated country and regional efforts to support
integration of EBHC at both undergraduate and postgrad-
uate levels. Evidence-informed strategies should be used
to direct how EBHC learning can be mainstreamed into
health professions education [39]. As part of themomentum toward transformative health professions edu-
cation [40], the process of curriculum review presents use-
ful opportunities to include and enhance EBHC learning.
For instance, the Committee for Undergraduate Education
and Training of the Health Professions Council of South
Africa has adopted a modified version of the CanMEDS
framework for establishing graduate attributes of a newly
qualified health care professional [41]. It provides a guide
to the essential competencies health professionals must
have to optimize patient outcomes. The framework defines
the attributes of the graduate according to seven interdepen-
dent roles: Medical Expert, Scholar (which includes most
of the aspects of EBHC), Professional, Communicator,
Collaborator, Manager, and Health Advocate.
Undergraduate training programs in South Africa are be-
ing reviewed to better reflect these attributes. This period of
change to the curriculum provides a window of opportunity
to introduce, strengthen, and integrate multifaceted EBHC
teaching and learning with assessment [39,42]. The process
starts by assessing the current curriculum [43,44] and moves
on to working with lecturers and program convenors to plan
pre-clinical and clinical EBHC learning, getting institutional
buy in, and enhancing the competencies of the trainers to
facilitate learning and, most importantly, acting as role
models [45,46]. In the course of these activities, academic in-
stitutions can benefit through sharing best practices and using
robust evaluations alongside implementation.
Researchers also need to understand how the policy pro-
cess and health system work and engage with policy
makers to understand their priorities and information
needs. This will guide efforts to access and interpret exist-
ing research, especially systematic reviews, conduct new
research (where necessary), and complete and communi-
cate research timeously and in appropriately tailored for-
mats [47], to inform decision making at both policy
development and implementation level. Clinical guideline
development can be enhanced by following standardized
approaches, followed by dedicated initiatives to support
guideline implementation and evaluation. National and
regional initiatives in this regard are in the pipeline. The
recently launched G-I-N Africa [48] describes itself as ‘‘a
regional community of clinical practice guideline devel-
opers, users, and other stakeholders from the African conti-
nent who are interested in improving the effectiveness,
rigor, and efficiency of guideline development, adaptation,
dissemination, implementation, and performance measure-
ment.’’ Initiatives such as these need support and engage-
ment from guideline development teams and ministries of
health to avoid unnecessary duplication and ensure sustain-
ability and impact.3.3. Partnership and collaboration are key guiding
principles
Collaboration between researchers and decision makers,
between academic institutions, between academic and
6 T. Young et al. / Journal of Clinical Epidemiology - (2016) -research institutions, and between cadres of specialist staff is
key tomoving toward the common goal of evidence-informed
health care practices in the African region. By sharing best
practices, collaborating and partnering on research and capac-
ity development initiatives, avoiding unnecessary duplication,
and building equitable [49] long-term relationships, African
efforts to promote EBHC will go further [34,50,51].4. Conclusion
There has been a rapid growth in various initiatives to pro-
mote EBHC in the African region.Much still needs to be done
to improve impact on health in the region.Working together in
mutually supporting partnerships is key to advancing both
evidencedinformed health care practices and better health.Acknowledgments
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